AVGR - Avinger Inc. Debt to Book Capitalization Ratio

Corporate company logo of Avinger, Inc. (AVGR)

Avinger, Inc. (AVGR) leverages unique Pantheris technologies that enable surgeons to clear arteries with high precision, driving business growth. The company's balance sheet financial leverage demonstrates a current reliance on borrowings, where the 1.39 level reflects the current magnitude of the debt load. Despite the management's technical expertise, scaling remains difficult, and moderate revenue from catheter sales is currently constraining aggressive capital expansion.

Avinger, Inc. - AVGR Debts to Book Capitalization (period 07/04/2022 - 02/22/2025)
Flagship merchandise of Avinger Inc

This ratio determines the degree of capital structure dependence on borrowed funds relative to equity. The trend of the company's total debt relative to its book capitalization allows for an assessment of excessive leverage risk. This metric measures the balance between financial stability and the cost of asset ownership. For Avinger, Inc. (AVGR), a moderate debt load provides the resources necessary to develop eco-friendly production of laser systems. Monitoring this indicator confirms ethical capital management during the modernization of factories.

Competitors of Avinger, Inc.

DXCM: Debts to Book Capitalization|penumbrainc.com - Debts to Book Value|Debt to Book Capitalization Ratio Novanta (NOVT)|HAE - Debt to Net Assets Ratio|INSP: Debts to Book Capitalization|PRCT (Procept) - Debts to Book Capitalization|Debt to Book Capitalization Ratio CONMED Corporation CNMD|Debts to Book Capitalization Ratio pulsebiosciences.com|InMode - Debts to Book Capitalization|Debts to Book Value Picard Medical Corp PMI|Debt to Book Value SRDX (Surmodics Corp)|SENS - Debts to Book Capitalization|Debt to Book Value NeuroPace, Inc. NPCE|TCMD - Debt to Book Capital|SANUWAVE - Debts to Book Capitalization|Outset Medical Inc (OM) - Debts to Net Assets|Debts to Book Capitalization ELMD|Debt to Book Value LENSAR Inc (LNSR)|AVITA Medical, Inc. (RCEL) - Debt to Book Value|Debt to Net Assets Ratio PROF (profoundmedical.com)|Baird Medical - Debt to Book Capitalization Ratio|Debt to Book Value EDAP TMS SA EDAP|APYX (Bovie Medical) - Debts to Book Capitalization|ICCM - Debts to Book Value|Debts to Book Capitalization pulmonx.com|TELA Bio (TELA) - Debt to Book Value Ratio|CTSO: Debts to Book Capitalization|Debts to Net Assets Sensus Healthcare Inc|Debts to Book Capitalization ZYXI (Zynex Inc)|Debt to Book Value electrocore.com (ECOR)|Debts to Book Capitalization RBOT (Vicarious Surgical)|Inspira Technologies Oxy B.H.N. Ltd. - Debts to Book Capitalization|ICU - Debt to Book Capitalization Ratio|IRIDEX Corporation (IRIX) - Debt to Book Capitalization Ratio|Debt to Book Value ibs.inc INBS|Beyond Air (XAIR) - Debt to Net Assets Ratio|Debts to Book Capitalization PFSA (Profusa Inc)|Debts to Book Value SSKN|GCTK: Debt to Book Capitalization Ratio|Debt to Net Assets NanoVibronix Inc. NAOV|Debt to Book Value VERO (Venus Concept Corp)|Debts to Book Capitalization Nuwellis Corp NUWE|Debts to Book Capitalization AEMD (Aethlon Medical)|ASXC: Debts to Net Assets|Debt to Book Capitalization Ratio Biosig Technologies (BSGM)|CUTR (Cutera Inc.) - Debts to Book Capitalization Ratio|Debt to Book Capitalization Ratio KNW|Debt to Book Value Inari Medical Corp|Nevro Corp. - Debts to Book Capitalization|Debts to Book Value RSLS (reshapelifesciences.com)|SILK - Debt to Book Capitalization Ratio